THE JAMES CROOKS MEMORIAL FELLOWSHIP IN CLINICAL PHARMACOLOGY &
THERAPEUTICS
Scottlsh Charlty Number: SC052561
Accounts for th• year to 31 Dec•m￿r 2024
Contents
Report of the Trustee5
Report by Independent Examlner
Accounts
Notes to the Accounts
Appendices of Investments
T**xvFe.' 01382229111 Fa¥.. 01382202288

The James Crnoks Memorial Fellowship in Clinxal Pharnwcology & Therdpeutl(s
Rewt rfthe Tn￿ for the year to 31 December2024
ee N(*es1
Prth)n hdj at tkndee Universty wth"n
r* ￿ i r*pabY￿1 ain￿1 Pharrrklcc
r¥<
AS9￿n￿l 24.IL2022
Trustees are nominatso t%1￿r9 tr￿te*S￿d I￿1r apwntsytht ¢orflm*d ty fomwl Deal ofAssumptkn.
The trustees <leal appw*tdy a5 regards indutti¢n Ind tra￿￿9 on any rth trustees 4v￿1n￿j. Thfjs Ipdudes awareress of
trust*'s r•)nsi￿litIe$. the otsvemino dtsJrf aJmnitrdtNe ￿T￿edu￿$. and the htstory and phik)sophlol approath of
the charfty. A new tru&ee vlll recd* COF¥es d the SmiOLsyears aCc￿nts, rn1r￿ ol recenl ts￿tee I￿etsr￿ aTr1 a copy of
the OSCR t¢okkt"GuldaKe good pra¢￿tr for Charty TrLt#eef, If apprwlate.
T￿rrtor6 Law LLP, Wnitthall HC￿e. 33 ye￿n￿ StrKf< EOI 48J
Estlyn Part￿rs, 177 Pthwel Stree( G*y4 G2 7eL
ndentExamh
athr, L￿a* LLP. TheV￿ ￿l￿31r￿ xi i>euwn¥krt DPI 4Q8
Scothsh Chty No,, SC052561
e[clar￿S include al or any one or rnore of'.- lal The UnNEr9ty Dejart￿t ot ￿rnacOI￿V and Clinical Pharma(Dlogy;
(bl The Phar￿￿￿tEl￿1 Industry." (E} Dcpirtsryts of Flbarn*tok¥Jy. ClinKd Phorn)acDk)9y ènd Therapeutics, In
pwtrcular. but Th)t exchJs(¥ely. Sn rethn to the bennlafty ty the UnNprsty OF f￿nd¢e VPDn tho reCornwda￿cn of
the Fdbwshp Trustee5 of a felly￿shIp li nwe of the f￿￿￿r￿j *w5:
By in¥itiThJ an a(knovleW expert in the fidd of FIkwrn￿C￿, aintsl Phamiaco¢yJy orTherapeubcsto spend a short
pErit*J ol al kasl b¥eek iry the University DeP￿tOr PhwfflKoby4yand a nKal [1￿[[na(0k￿y, during whith pErKxJ
the fellow appointed ￿11 gi¥* a Jrn Cm)ks Le￿re aThJ a wies of s¢rninars ftsr stsff •nd PU#gradu•t¢
swdents:

The James Crooks Memorfal Fellowshlp In Cllnlcal Phamjacology & Therapeutics
Reportof the for the yearto 31 December2024 <a￿t)
9Jkwting a Y(￿￿j T￿e&th in C)nKal Pharm￿o￿Th cf reL)ted fiebts kn thith the UnNer5rty for
extended peri*# of re5eath of up to v*ithn the DepartTrwrt cl Pharmacdr4y and Cknlcal
Phamiacokgy; aTrJ
Suppo￿.￿ a member ofthe staff in FfiuMXo￿0TrelJted in urbJertJkiw a
of fvrther traini￿ in a Cwartsnent ￿ ainical Phar[Th￿Y ￿ther within o or within the pharmaceuLtal
Inthjstry,.
The day.to4ay admlnlstratth 6 carr*d ¢xrt ty Thcrtons Law LLP, as &*nts for the TnJsL The trustees amualty to
conslder grant appllcath)r￿ and to any other reknnt a9)￿ts ¢Ythe Trusvs aff&
The trustees have Con￿n￿e￿ thetr pjky ol makJtvJ (knat￿ to tt#xe ar#1 Ir&Ututb)r& as dlreded In the trust deed.
flnantes of the tru5L xe 5althd that are in to rn￿4ate exrK)sure to those n5ks. The tW5tees corfjider
varfaly.llty of In¥estrtRnt retun￿ to (￿thte the thènvs mw f￿￿01 TNS ts mibgèted try retèSnin9 expert investment
managers and ￿n9 a dl¥ershJed Ir￿e5￿￿￿t
There are rn re5trfction5 In the Deal C￿ the tnffjtee5' W to Inrt The p)Hcy Is, ILW ierni, to Jdrpt J methym rf5k
Invèstsnent Straw, IndLkllThJ 4ulty Investr￿nts, to wC#ju￿ a baknce of IrK(Kr￿ ar￿ captsl grth,
The flnantkal as sèt F•Je5 5 4TrJ 6.
The reserve5 ofthe Trust orfglnate from Dr*lnal afbj sub5eiwrt capltal te4ue5ts, tr*Jether wTth the ￿vernent In ts value of
Investrnents, and accurnulated revenue. Tr trustee5 have adop￿ a reserves that ensures the conUnulrvJ ab11Ity of the
Tnjst to rneet ts objethw. The thl of I￿e reserlts W at 31 c￿erni￿ 2024 was £198,666.6112023 £197.19q.08}.
Fvtur• Shttyy
No charyes a￿ presenty envlw in the tntsys as tyJVln&J atam.

The James Crooks Memorlal FelloTNshlp In Clknkal Pharnwokngy &Thernpeull¢>
Independent Examinerfs Report to the tNstees of The James Crooks Memorial Fellowship
In ainlcal Pharniacology & Therapeutlcs
I report on Ihe a¢court% Of the d￿rtY ftjr Ihe wiodeThJed 31 Dtxtthr 2024 whKh n xt outon 5 te 9.
This rewrt is rnade to thetr￿tee5, as a toty, in Kc((tsnce wth the tems of erwmert. Ny %wrk has LEen undertaken
to erK*ble to report ryry opinw set tyjt below for rK) (ts purp)se. To the extent Ferynthd I do n¢t
cert ty •4ume resrlwsttllty to anytr* Lthr thantht tru5W. a$ 4 t￿. for my 14wk or ts this reprt
Rospectlve nsponsibllitla% of trusioes •nd examln
The trustees a￿ responsible for the preparatrm of the ac£ounts kn ac￿1￿•￿e terms of the Charltles and Trustee
Investment Iscothnd) Act 2QOS and the tharbes Accounts (Smtkndl Wuhb"cr6 20C6 las amendadl. The trust￿ CL￿der
tlwt the au(k't reqUI￿rrent of Regu￿￿ ILYI){al to Ic} of the 2CrfJ6Pa￿ts Wulat￿n5 O)e5 not atdy. 11 i5 ry re5ponsithlty
to exarnine the acamjts as requir8J undaT sth 41tll (cl rf the kt afft1 to gate whether partscuL31 mattws h￿e come to
ry att¢rty)n.
B•sls ¢1 Indwndont slatoffl
fv exaTr¥n*on Is ¢x* kn x¢tyd•n￿ wlth re9Jl#bx 11 of the I(￿ A¢mw*s ie9Jl•#ws. Indu¢es •
re41ew of act￿nt￿¥ keo by the eharfty and a cc*np*15c• d tl* ￿nts Jxe5ertt•Y ￿th recc(d& It a19)
Indudes cordderabon of any unusual ftems cYdsdosJres In the x¢ounts. arnl seekseXplanatic￿fr¢M tk trustees¢oncwnir
any 9xh matters. Tr prO￿ureS LtTrJertaken ts) r¥)t wvide &1 the ev¥Jertt thw. be requ￿fj In an aLK1f(, ar
consequentty I do ￿t exwess an aK1r( Op￿1￿ on trrt ty tr* Kcoun
Indqxndlnt •x•mln•rfi •lJt•rn
l. vthch glves rne M￿nable causeto teknethrt In w rnattr*l respect the wutrerrats..
to keep accoUn￿n9 records h accordancetpAlh stttson 4411) la) 2C#J5 N£t aThl IWuLItlDn 4 01 the
2006 kcounts Regulatin5, ar
to p￿pare KCOu￿ wNth the acaKniing cunFty wlth Re9uk*k>n 8 of the 2CQ6
unts Re9U￿￿on$
halt rot been nrt or:
2. tr) whkh. in my 0￿￿kIn, allenlkn slwkl bedrawm In order to enai* a pyopu urbkn5tandlr4J rA ￿ accounts to t
Partrier
For and on tehalf (* Logg* LLP
ThE V15im ￿5￿1[￿j
20 Greerrnwket
Dundee
DDI 4QB
23 Septembw 2025

The James Crooks Memorial Fellowship in Clinical Pharnwcokn &Therapeutics
Recelpts and Payments Aec¢unt for the year ended 31 December 2024
2024
2023
Rec•lpts
3W.SI
2,798.36
115 6x34
108 730.93
Totsl recdpts
119
90.85
111529.29
PJyment•
CharIta￿e atht*s
471X>.IXI
2,310.
4,141.68
3,484.16
Cost orwer￿ffj fur
9O7A7
rthase of Investrnwts
113,00&06
114,166.62
T¢tal
757.61
dt for the yew
3 266.76
8 431.49
I runds are unfe5tr1cted.

The Jame5 Crooks Memorlal Fdlowshlp In aknkal Pharma(x>kngy & Therapeutlcs
statement rf Balances as at 31 Dec•nber2024
2024
2023
Cash on deposlt and on h•NI
Owing bakin
6,579.08
Fun(ts trar￿re￿ to Charlty
15,01057
Deftit for the year
aos*ng bakn
3 31132
6 579.08
Unrestrict6J Funds
3 31132
6 579.08
As valued at 31.12.24
Ertlmated Ulbllltlos •s rt 31.12.24
Thornwns Lasy LLP, Idtnln15traUw fee5
Evetyn P¥rtnws, porfolio rnanwert feBS
llldepend￿t Examlner Fee
3,12ts.IXI
557.71
L12LOO
2,4)0.00
1,020.tr)

The James Crooks Memorlal Fellowshlp In Cllnlcal Pharnmcology & Therapeutks
Sthedule I
2024
2023
Dfvhjends Jnd Intrrest. P¥AFFe￿i¥ I
3M56JI
2,798.36
Sche(lule Z
Charftsbl• A¢llvltk•
D￿trI￿￿On$ m#dE in yur1£SLKJ to 4 iTh*¥Aduals)
Suwort c¢sis {ScheJJle 31
oooJ)o
4700.00
1310.(
2024
T•l*l
Thcrntons, th•"r fee for Trust adrnnislnt
¢wmioons, p0&5 erc. fcv the pemtsj to
31.12.24 (inc VAT)
¥700.00
700.00
4400.00
HeTrJerson LwJie- IndeF￿t examlnatkn
of the 2023 kcounts
¥020.00
020.¢0
Rer*wal Athsory R￿Urner•I￿ -
3QO.¢J
Custody Charge5
121.05
141.68
700.00
841.6•
edu* 3
Supp)rt c
Ch**aYe
2023
Tcl)I
Thomtons, their fee ft)r Tnst *Jmlnlswats)n.
rnmi55iws, etG forthe wiod to
ICL
2,3IOD)
4,620.C
31.12.23 vAr)
Renewal Adwwry Renun￿•1￿*1-
I,orAo?
I.CW.07
Custcth Char5e5
16&09
166.09
No Trustees reoNed any ￿￿nerati￿ (Y frcth Ihe Trtst luriNJ thi% ry lhe￿￿eth￿J yew.
The Tnst has no employ

The James Crooks Memorfal Fellov•shlp In Clinical Pharmacology & Therapeuti
SCI￿lUIe 4
2024
2023
907.87
SCI￿d￿le S
StJtern¢nt of Revenue bJlJnce M at 31.12.24
2024
2023
Income rttew In the
3M3.20
2,798.36
LlstdtArtlons pak1 to benefid*s
SuppJrt costs
[1000.00)
1700.00
(816.80)
3,484.16
{685.80)
801￿￿ a5 al 31.12.23
8a1￿ce as at 31.12.24
150160
685.80

The James Crooks Memorial Fellovtship in ainical Pharn￿Col0gV & Therapeuti
Notes to the Accounts and General Notes regardlng the Flnanclal Servlces and Markets Act
2000, Law Society Rules and related mattevs
Basls of Prnparation
The Accounts are prepared In accordance wlth the Charftles Accounts (Scotlandl RegUla￿onS 2006 (as
amended).
Investments etc
In these Accounts stocks and shares, gllts, debentures and warrants are valued at thelr Stock Market valye, If
Ilsted on a registered Stock Exchange, or otherwise at either li) the latest available valuation known to us or
li1} cost, at our discretbon. Unit Trusts are valued at their approximate bid price. ￿fe Assurance politie5 are not
valued.
Reolised 9alns or losses are transferred to Capltal. Unrealised appreaatl¢*n or depreciation In the value of
Investments- as compared to thelr CGT base costs - Is dealt wlth under-AdJu5tment on revaluatlon/rebaslng".
Contract Not•s
In terms of our Law Soc*ety Rules we a￿ requlred to fornard coples ol all Contract Notes relatlng to the sèle
or purchase of Investments to cllents. In the case ol Trusts we fulfil thls requlrtment by forwarding a copy to
the first named Indepent1ent Trustee {i.e. a Trustee who 15 Flot a partnerlnominee cornpany of our flmi) based
on the order of Trustees set out ort the fitst Pa9e of the Trust AC￿unts, unless otherwlse agreed.
Stockbrnker Commlsslons
As ￿l￿bur$ement of stockbroker commlssions recelved on the purchase or sale of stocks and shares Ss
admlnistratlvely expenslve and as the amounts Involved are normally falrfy mlnor, our pract*￿ Is not to
relmburse such COMMI￿lon$ to the Trust. but to take them Into account In the overall assessment of our fees.
Any commlsslons recelved through Thorntons Investment Managers a￿ retalne(1 in full unless otherw15e agreed.
Investment Managers
The Trustees approve the contlnued appolntment of the Investment Mafiagers as detalled In the General
Inforrnotlon sectlon In these Accounts, and on the ￿me bos15 as contalned In the Investment and ￿nancIal
Sèrvlces Terms of Buslness Agreement currently In force.
hTomln¢eshlp.'
The trustees approve the appolntment of the nominee company as detalled In the General Informafjon sectlon
In these Accounts to contlnue to hold certain or all of the investrnents owned by the trustees, and that on the
same basls as contalned In the Investment and Flnanclal serv1￿5 Temis of Buslness Agreement currently In
force.
Independent Examln•r
The trustees apprDve the contlftued Ippolntrnent of the Independent examlner as detalkd In the Report of the
trustees In these Accounts.
Golng con￿rn
At the time of appro￿n9 the flnandal statèments. the trustees have a rea9)nable expertatlon that the Trust
has adequate resources to continue in operational existente lor the foreseeable future. Thus the trustees
continue to adopt the golng concern basls of accouning In preparfng the finafioal statements.

aNlThera
oun
Dividends & lrtt¢rEst rKeryed in the period ended 31 Oecember Z014
05101n024 J P MORGAN GLo￿LGRoWfH • INCOME P OADGBPO.OS
1210112024 Fund Cash Rebare No¥embtr 23
1810112024 FIDELITYGLOUL DIWDENDW INC
3UOII2024 TB EVENLODE INVESTMENTFUNDS ICVCTB EVEf4LODE INCOME F
OYIOV2024 Fund Cash Robat• Det¢mber 23
2310212024 IKTOPUS RENEWABIES INFKdSTrUCTUAE
2810212024 RATHBONE UNfTTRUST MANAGEMeNT LTD iITHBONE ETHICALBO
1310312024 Fund Cash Rebatejanuary 2024
2810312024 IFSL MARL8OROUGH NO 2 OEIC IFSL MAALKSROUGH MVLlItAP
W0312024 VONTO8EL FUNOTWENTYFOVR SHORTTERM BOND
3110312024 BAIiLIE GIFFORDVK & ￿FD$ ILYC
1510412024 Fund C•sh Rebate February 2014
1610412024 JPMORGAN GROWTH & INCOME ORD 5P
1810412024 FIOELITY IW FOSGLOBAL DIVIDEND FUND
2210412024 VK GOVT3.5% 22110115
30IL412024 TB EVENLODE INVESTMENT FUNDS ICVCTB EVENLODE INCI)ME F
171OS11024 FINseLJRY GROWTh & INCOMÉ TRUST OHD 25P
2010511024 FIDELrrYGLOBAL DMDENDINC
3110S12024 RATHBONE VNITTAUST MANAGEMENT LTDILAThBONE UHICAL80
1810612024 FIDELIIY GLO&4LOMOENDINC
28IW2024 VONT08EL FUNDTWENIYFOUR SHORTTERM B014D
0110712024 BAILLIE GIFFORO UK & 8AL FDS IThC
0310712024 IPMORGAN GAowfH & INCO•AE ORO 5P
1810712024 FIDELITY GLoeAL DMDÉND INC
3010712014 UK Govfo.125% 30101126
3110712024 UK Gowf3.25% 31101133
3110712024 ARTEMIS INV FUNDSCORPOAATE OONO
011￿11024 TB EVENLOOE INVESTMENT FUNDS ICVCT8EVE14LODE INCOME F
C*JICffjI2024 8NY MELLON GLO8AL FUIIDS US EQu￿y INCOME
1910812024 FIDELtTYGLOBAL DMDENO IPK
C$1￿12014 VKGOVT 3.75%07103127
1810912024 FIDgLtTY6LOBAL DIVIDENO INC
26109n024 JPMOFIGAN GLOML OPPS SU
3010912024 VONTO8EL FVNDIWENIYFOUR 5HORTTEPM 8QND
10912024 6AILLIE GIFFORO UK & 8AL FD5 KVC
0711012024 JPMOR&4N GROWTH & INCOME ORO 5P
1811012024 FIDELITY GLoeAL OMDEND INC
1211012024 UK Govf 3.5%2V10125
3111012024 TB EVENLODE INVESfMEpifFVP4D51CVCIB EVENLOOE INCOME F
3111012024 ARTEMIS INV FUNDS CORPORATE bOND
11112024 BNY MELLON GLOOAL FUNDS USEQIJIIY INCOME
CI11112024 FIN58URYGRowfH & INCOME TRUSTORD25P
18IIu2024 FIDELITYGLO8AL OIWDEND INC
1811212024 FIDELITYGLOBAL DIWDENO INC
3V12no24 VONTOBEL FufiDIWENTYFOUR 5HORTTERM 8OND
3111212024 BAILUE GIFFORD UK & UL FOS ICVC
iU.66
0.36
0.38
1.12
138.63
154.84
180.96
93.•)
125.67
127.26
IS7.45
iyJ.>J
27.83
143.96
2Y.83
76.27
75.76
115.67
27.83
153.76
47.47
.49
20.63
27.83
122.51
27.83
o.oi
82.26
74.86
S.38
27.83
157.45
10.49
98.12
41.%
109.40
27.83
17.83
87.49
74.06
Int?rest fecemdforthewtsjto JI Ewh*•2024
S7.66
3.866.51

TheJarn¢s Crooks Memorfal Fellowshl alnfjcal Pham
dlx
Accounts for the
ried ended 31 Oecembef 2024
Investment sales and purthase5 forthe period ended 31 Oecernber 2024
Units
In¥estment
Sales
0510412024
12.422 ocropus RENEWA8LES INFRA TR PLCORD GBPO.01
0810412024 13.330.07 RATHBONE UNITTRUST MANAGEMENT LTD RATHBONE FfHICAL 8OND I DIS
0810412024 6,193.724 IFSL MARLBOROUGH MULn CAP INCOME P DIS
0810412024
81.222 VONTOBEL TWENIYFOUR SHORTTERM BONO
0810412024
149.41 JPMORGAN GLOBAL BD OPPS
3010712024
451 XTRACKERS PHYSICALGOID
30A)712024
354 FIN58URY GRowfH & INCOME ORD 25P
3110712024
2,163.3 INVESCO EUAOPEAN INV EUROPEAN EQUITY UK Z
3110712024 5,365.659 HEftiof INV FUNOS GLOBAL AACC
8.803.12
11,371.88
8.254.38
7.607.25
13.923.52
5.581.35
2.993.21
10.707.25
16.847.63
IFI
3110712024 38.6538 TM FULCRUM DIVERSIFIED ABST REfuRN ACC
3110711024
119.82 TRIUM UCITS PLATFORM EMISSIONS IMPROVERSACC
3110712024
O ARTEM15 INV FUNDS CORP 8OND- t9￿1154t10Th
0910812024
0 8NY MELLOP4 GLoeAL FOS LIS EQUtrY INC- equ￿1$￿￿0ft
0411112024
352 JPMORGAN GLOBAL GRowfH & INCOME ORD 5P
0511112024
2,515 FIDELITY GLOBAL DIVIDEND INC
0811112024
O BNY MELLON GL08AL FOS US EqU￿V IMC.equ411satlon
18112n024
1628 LIONTrUSTEUROPEAN DYNM ACC
5.827.45
15.219.$4
49.71
22.05
2.Ch)3.79
2.987.82
6.41
3.417.98
115,624.34
Purchases
0510412024
8.997 UK ￿3.5% 8DS 22iion5
0510412024
9.076 UK GO￿3.75% BOS 07103n7
0510412024
9.462 UK GO￿3.25% BOS 31101133
0510412024
9.680 UK Goyf 0.125% BDS 30101126
0810412024 7,612.CIJS ARTEMIS INV FUNDSCORP BOND
0810412024 4.160,475 &NY MELLON GL0&4L FDS US EQU￿Y•Nc
3010712024
301 KfRACKERS PHYSICAL GOID
3010712024 135.341 L)ODGE & COX WORLDWIDE US STOCK
3010712024
263.84 GUINNESS JSSET MANAGEMENT GLOBAL EQUIIYINCOME Z
3110712024 4.923.869 LioMfRusf PARTNERS EUROp￿N DYNM ACC
31107120Z4
53.97 NATIX15 INTERNATIONAL GRowfH EQUITY
31107n024
69.94 TAIUM UCITS PLATFORM CLIMATE IMPAcfACC
31107D024 1.780.838 BNY MELLON GLOBAL FDS US EQUtrY INC
0110812024 66.5583 MONfL4KE UCITS MYGALE EVENT DRIVEN
1511012024
I,C84 ARTEMIS INV FUNDS COAP BOND
15Jion024
6 NATIXIS INTERNAMONAL GRowfH Eourry
1811212024
850 PREMIER MITON INVESTMENT FUNDS USOPPSACC
9.OX.88
9,Q43.87
8,993.74
8,998.69
6,967.27
6,960.06
8.506.20
&oyJ.oi
8.C*JO.05
6.500.00
9.1MX).04
6.999.60
3.lYJO.IXS
7.lY)O.00
LW4.07
1.060.68
3.972.90
113.DJ8.06

4 ¥ ¥

Z J 3
r.